EP3152234 - ANTIBODY WHICH IS DIRECTED AGAINST GALECTIN-9 AND IS AN INHIBITOR OF THE SUPPRESSOR ACTIVITY OF REGULATORY T LYMPHOCYTES [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 24.05.2024 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 05.06.2020 | ||
Former | Grant of patent is intended Status updated on 27.04.2020 | ||
Former | Examination is in progress Status updated on 26.01.2018 | ||
Former | Request for examination was made Status updated on 10.03.2017 | ||
Former | The international publication has been made Status updated on 09.12.2016 | Most recent event Tooltip | 24.05.2024 | Patent maintained (B2 publication) | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states Université de Lille 42, rue Paul Duez 59800 Lille / FR | For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3, rue Michel-Ange 75016 Paris / FR | For all designated states Institut Gustave Roussy 39, rue Camille Desmoulins 94800 Villejuif / FR | For all designated states Cellvax 102 avenue Gaston Roussel 93230 Romainville / FR | For all designated states Université Paris-Saclay Espace Technologique de Saint-Aubin Immeuble Discovery Route de l'Orme des Merisiers - RD 128 91190 Saint-Aubin / FR | [2020/24] |
Former [2017/20] | For all designated states Université des Sciences et Technologies de Lille 1 Cité Scientifique 59650 Villeneuve-d'Ascq / FR | ||
For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3, rue Michel-Ange 75016 Paris / FR | |||
For all designated states Institut Gustave Roussy 39, rue Camille Desmoulins 94800 Villejuif / FR | |||
For all designated states Cellvax 102 avenue Gaston Roussel 93230 Romainville / FR | |||
For all designated states Université du Droit et de la Santé de Lille 2 42 rue Paul Duez 59800 Lille / FR | |||
For all designated states Universite Paris-Sud 15, rue Georges Clémenceau 91400 Orsay / FR | |||
Former [2017/15] | For all designated states Université des Sciences et Technologies de Lille 1 Cité Scientifique 59650 Villeneuve-d'Ascq / FR | ||
For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3, rue Michel-Ange 75016 Paris / FR | |||
For all designated states Institut Gustave Roussy 39, rue Camille Desmoulins 94800 Villejuif / FR | |||
For all designated states Cellvax 102 Avenue Gaston Roussel 93230 Romainville / FR | |||
For all designated states Université du Droit et de la Santé de Lille 2 42 rue Paul Duez 59800 Lille / FR | |||
For all designated states Universite Paris-Sud 15, rue Georges Clémenceau 91400 Orsay / FR | Inventor(s) | 01 /
DELHEM, Nadira 10 Rue Adolphe Torgue F-59700 Marcq en Baroeul / FR | 02 /
BUSSON, Pierre 8 Rue du Moulin F-92160 Antony / FR | 03 /
MORALES, Olivier 10/12 Rue du Priez F-59000 Lille / FR | 04 /
BARJON, Clément 36 Boulevard Maxime Gorki F-94800 Villejuif / FR | 05 /
MRIZAK, Dhafer 101 Rue Colbert F-59000 Lille / FR | 06 /
LHUILLIER, Claire 49 Rue du Général Leclerc F-94270 Le Kremlin-Bicêtre / FR | 07 /
MUSTAPHA, Rami 275 Rue des Postes (3ème étage) F-59000 Lille / FR | [2017/15] | Representative(s) | Plasseraud IP 104 Rue de Richelieu CS92104 75080 Paris Cedex 02 / FR | [N/P] |
Former [2020/28] | Plasseraud IP 31, rue des Poissonceaux CS 40009 59044 Lille Cedex / FR | ||
Former [2017/15] | Cabinet Plasseraud 31, rue des Poissonceaux CS 40009 59044 Lille Cedex / FR | Application number, filing date | 15732846.9 | 05.06.2015 | [2017/15] | WO2015FR51498 | Priority number, date | FR20140055177 | 06.06.2014 Original published format: FR 1455177 | [2017/15] | Filing language | FR | Procedural language | FR | Publication | Type: | A2 Application without search report | No.: | WO2015185875 | Date: | 10.12.2015 | Language: | FR | [2015/49] | Type: | A2 Application without search report | No.: | EP3152234 | Date: | 12.04.2017 | Language: | FR | The application published by WIPO in one of the EPO official languages on 10.12.2015 takes the place of the publication of the European patent application. | [2017/15] | Type: | B1 Patent specification | No.: | EP3152234 | Date: | 08.07.2020 | Language: | FR | [2020/28] | Type: | B2 New European patent specification | No.: | EP3152234 | Date: | 26.06.2024 | Language: | FR | [2024/26] | Search report(s) | International search report - published on: | EP | 18.02.2016 | Classification | IPC: | A61P35/00, A61P35/02, A61P43/00, C07K16/28, C07K16/30, A61K39/00 | [2023/47] | CPC: |
C07K16/2851 (EP,US);
C07K16/18 (CN,US);
A61K39/3955 (US);
A61K45/06 (US);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
C07K16/30 (US);
C07K16/3084 (EP);
C07K16/3092 (CN,US);
A61K2039/505 (EP,US);
C07K2317/34 (EP,CN,US);
|
Former IPC [2017/15] | C07K16/18, C07K16/30 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/15] | Title | German: | GEGEN GALECTIN-9 GERICHTETER ANTIKÖRPER ALS HEMMER DER SUPPRESSORWIRKUNG VON REGULATORISCHEN T-LYMPHOZYTEN | [2017/15] | English: | ANTIBODY WHICH IS DIRECTED AGAINST GALECTIN-9 AND IS AN INHIBITOR OF THE SUPPRESSOR ACTIVITY OF REGULATORY T LYMPHOCYTES | [2017/15] | French: | ANTICORPS DIRIGÉ CONTRE LA GALECTINE 9 ET INHIBITEUR DE L'ACTIVITÉ SUPPRESSIVE DES LYMPHOCYTES T RÉGULATEURS | [2017/15] | Entry into regional phase | 08.12.2016 | National basic fee paid | 08.12.2016 | Designation fee(s) paid | 08.12.2016 | Examination fee paid | Examination procedure | 08.12.2016 | Examination requested [2017/15] | 08.12.2016 | Date on which the examining division has become responsible | 21.07.2017 | Amendment by applicant (claims and/or description) | 29.01.2018 | Despatch of a communication from the examining division (Time limit: M04) | 05.06.2018 | Reply to a communication from the examining division | 07.09.2018 | Despatch of a communication from the examining division (Time limit: M04) | 08.11.2018 | Reply to a communication from the examining division | 07.12.2018 | Observations by third parties | 15.01.2019 | Observations by third parties | 29.03.2019 | Despatch of a communication from the examining division (Time limit: M08) | 09.12.2019 | Reply to a communication from the examining division | 12.02.2020 | Observations by third parties | 17.02.2020 | Observations by third parties | 28.04.2020 | Communication of intention to grant the patent | 30.04.2020 | Fee for grant paid | 30.04.2020 | Fee for publishing/printing paid | 30.04.2020 | Receipt of the translation of the claim(s) | 07.05.2020 | Observations by third parties | Divisional application(s) | EP20184087.3 / EP3747908 | Opposition(s) | Opponent(s) | 01
08.04.2021
06.07.2023
WITHDRAWN Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2023/33] |
Former [2021/20] | |||
Opponent(s) | 01
08.04.2021
Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | 23.04.2021 | Invitation to proprietor to file observations on the notice of opposition | 25.10.2021 | Reply of patent proprietor to notice(s) of opposition | 11.07.2023 | Cancellation of oral proceeding that was planned for 12.09.2023 | 11.08.2023 | Despatch of a communication from the opposition division (Time limit: M02) | 12.09.2023 | Date of oral proceedings | 11.10.2023 | Reply to a communication from the opposition division | 02.11.2023 | Despatch of interlocutory decision in opposition | 12.11.2023 | Legal effect of interlocutory decision in opposition | 12.02.2024 | Despatch of communication that the patent will be maintained as amended | Fees paid | Renewal fee | 30.05.2017 | Renewal fee patent year 03 | 28.05.2018 | Renewal fee patent year 04 | 27.05.2019 | Renewal fee patent year 05 | 22.05.2020 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 08.07.2020 | CY | 08.07.2020 | CZ | 08.07.2020 | EE | 08.07.2020 | LV | 08.07.2020 | MC | 08.07.2020 | MK | 08.07.2020 | PL | 08.07.2020 | RO | 08.07.2020 | RS | 08.07.2020 | SK | 08.07.2020 | SM | 08.07.2020 | BG | 08.10.2020 | [2024/22] |
Former [2023/30] | AL | 08.07.2020 | |
CY | 08.07.2020 | ||
CZ | 08.07.2020 | ||
EE | 08.07.2020 | ||
LV | 08.07.2020 | ||
MC | 08.07.2020 | ||
PL | 08.07.2020 | ||
RO | 08.07.2020 | ||
RS | 08.07.2020 | ||
SK | 08.07.2020 | ||
SM | 08.07.2020 | ||
BG | 08.10.2020 | ||
Former [2022/08] | AL | 08.07.2020 | |
CZ | 08.07.2020 | ||
EE | 08.07.2020 | ||
LV | 08.07.2020 | ||
MC | 08.07.2020 | ||
PL | 08.07.2020 | ||
RO | 08.07.2020 | ||
RS | 08.07.2020 | ||
SK | 08.07.2020 | ||
SM | 08.07.2020 | ||
BG | 08.10.2020 | ||
Former [2021/28] | AL | 08.07.2020 | |
CZ | 08.07.2020 | ||
EE | 08.07.2020 | ||
LV | 08.07.2020 | ||
PL | 08.07.2020 | ||
RO | 08.07.2020 | ||
RS | 08.07.2020 | ||
SK | 08.07.2020 | ||
SM | 08.07.2020 | ||
BG | 08.10.2020 | ||
Former [2021/25] | AL | 08.07.2020 | |
CZ | 08.07.2020 | ||
EE | 08.07.2020 | ||
LV | 08.07.2020 | ||
PL | 08.07.2020 | ||
RO | 08.07.2020 | ||
RS | 08.07.2020 | ||
SM | 08.07.2020 | ||
BG | 08.10.2020 | ||
Former [2021/22] | CZ | 08.07.2020 | |
EE | 08.07.2020 | ||
LV | 08.07.2020 | ||
PL | 08.07.2020 | ||
RO | 08.07.2020 | ||
RS | 08.07.2020 | ||
SM | 08.07.2020 | ||
BG | 08.10.2020 | ||
Former [2021/10] | LV | 08.07.2020 | |
PL | 08.07.2020 | ||
RS | 08.07.2020 | ||
BG | 08.10.2020 | Cited in | International search | [XI]WO2010084999 (PROTEGENE INC [JP], et al); | [A]WO2012177788 (JOLLA INST ALLERGY IMMUNOLOG [US], et al); | by applicant | EP0173494 | WO9514785 | WO9622378 | WO9845322 | US5882877 | EP1586325 | other | WO2010084999 | US8329660 | Opposition | WO2010084999 | US8329660 | WO2014144600 | WO2016073299 | WO2021139682 |